Indian scientists have created an innovative self-actuating drug delivery system for Rheumatoid Arthritis, providing precise ...

AnaptysBio may have ended last year on a low, but 2025 is looking up with the news that its PD-1 agonist rosnilimab has ...

AnaptysBio stock whipsawed Wednesday despite promising results for its experimental rheumatoid arthritis treatment.

AnaptysBio’s Phase IIb trial of its rheumatoid arthritis (RA) treatment, rosinilimab, has seen some patients achieve the ...

PORTLAND, KS, UNITED STATES, February 13, 2025 /EINPresswire / -- Rheumatoid arthritis is an autoimmune disorder, w ...

Indian researchers have made a significant leap in the treatment of Rheumatoid Arthritis (RA) with a revolutionary “self-actuating” drug delivery system. This cutting-edge approach aims to ...

Arthritis and bursitis are common joint pain causes, but differ in origin and treatment. Arthritis inflames joints due to ...

Understand RA from early to advanced stages. Explore symptoms, treatments, and lifestyle tips to manage rheumatoid arthritis ...

Rheumatoid arthritis is an autoimmune condition ... Treatment: Arthritis treatment includes physical therapy, medications, and regenerative options like BMAC. Bursitis treatment focuses on rest ...

Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with ...

The FDA has approved Avtozma® (tocilizumab-anoh), a biosimilar to Actemra®, in both intravenous and subcutaneous formulations.

The vagus nerve, a complex bundle of 200,000 fibers connecting the brain to vital organs, has remained a medical enigma for ...